NEDD1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.31894495325469E-13 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.21920000048814E-08 |
Normal-vs-Stage2 |
6.245900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.656300E-03 |
Stage1-vs-Stage2 |
7.686000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.187800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.388800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.29150040556669E-11 |
Normal-vs-AfricanAmerican |
1.637760E-01 |
Normal-vs-Asian |
8.555200E-03 |
Caucasian-vs-AfricanAmerican |
2.075800E-01 |
Caucasian-vs-Asian |
1.445170E-01 |
AfricanAmerican-vs-Asian |
9.306800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.67970000031615E-07 |
Normal-vs-Female |
8.75619999840538E-08 |
Male-vs-Female |
7.160600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.215700E-03 |
Normal-vs-Extreme_Weight |
1.82610000454275E-08 |
Normal-vs-Obese |
1.778270E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.730800E-01 |
Normal_Weight-vs-Obese |
1.288400E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.795200E-03 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.575500E-02 |
Normal-vs-Age(41-60Yrs) |
1.834590E-04 |
Normal-vs-Age(61-80Yrs) |
6.28899998744714E-09 |
Normal-vs-Age(81-100Yrs) |
2.030800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.234360E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.321100E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.443980E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.601200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.521600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.509400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.293800E-01 |
Normal-vs-Grade 3 |
3.487600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.501580E-01 |
Grade 2-vs-Grade 4 |
7.293800E-01 |
Grade 3-vs-Grade 4 |
3.487600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.38630012919339E-10 |
Normal-vs-N1 |
1.502040E-03 |
N0-vs-N1 |
4.435600E-01 |
|
|